Ameriprise
TRDA icon

Ameriprise’s Entrada Therapeutics TRDA Stock Holding History

Ameriprise’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$887K Sell
70,280
-14,613
-17% -$167K ﹤0.01% 3352
2025
Q4 		$873K Buy
84,893
+14,967
+21% +$126K ﹤0.01% 3399
2025
Q3 		$406K Buy
69,926
+24,980
+56% +$146K ﹤0.01% 3698
2025
Q2 		$302K Buy
44,946
+3,923
+10% +$31.6K ﹤0.01% 3695
2025
Q1 		$371K Buy
41,023
+399
+1% +$4.97K ﹤0.01% 3606
2024
Q4 		$702K Buy
40,624
+2,517
+7% +$45.6K ﹤0.01% 3400
2024
Q3 		$609K Buy
38,107
+24,560
+181% +$387K ﹤0.01% 3418
2024
Q2 		$193K Buy
+13,547
New +$193K ﹤0.01% 3697

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return